Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aptargroup (ATR) EBT (2016 - 2025)

Historic EBT for Aptargroup (ATR) over the last 17 years, with Q4 2025 value amounting to $91.5 million.

  • Aptargroup's EBT fell 2114.93% to $91.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $491.4 million, marking a year-over-year increase of 460.08%. This contributed to the annual value of $491.4 million for FY2025, which is 460.08% up from last year.
  • According to the latest figures from Q4 2025, Aptargroup's EBT is $91.5 million, which was down 2114.93% from $154.1 million recorded in Q3 2025.
  • Over the past 5 years, Aptargroup's EBT peaked at $154.1 million during Q3 2025, and registered a low of $66.2 million during Q3 2021.
  • Moreover, its 5-year median value for EBT was $96.2 million (2021), whereas its average is $99.6 million.
  • As far as peak fluctuations go, Aptargroup's EBT plummeted by 2569.58% in 2021, and later surged by 4395.56% in 2024.
  • Over the past 5 years, Aptargroup's EBT (Quarter) stood at $80.2 million in 2021, then decreased by 8.16% to $73.7 million in 2022, then grew by 9.41% to $80.6 million in 2023, then surged by 43.96% to $116.1 million in 2024, then dropped by 21.15% to $91.5 million in 2025.
  • Its last three reported values are $91.5 million in Q4 2025, $154.1 million for Q3 2025, and $139.7 million during Q2 2025.